A Study in Moderate to Severe Rheumatoid Arthritis

Clinical trial NCT01710358 · COMPLETED

Trial details

NCT number: NCT01710358
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2012-10-01
Primary completion: 2015-03-01
Enrollment: 1307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.